C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2006
12/21/2006	WO2002087306A3 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
12/21/2006	US20060288455 modifying plant gene expression and/or by modifying plant haemoglobin levels in a plant; genetic engineering; altering tolerance in plants to various environmental stresses and to increasing seed yield
12/21/2006	US20060288454 Plants having modified growth characteristics and method for making the same
12/21/2006	US20060288450 Plant N-acylethanolamine binding proteins
12/21/2006	US20060288449 Process for purifying target compounds from plant sources using ceramic filtration
12/21/2006	US20060288443 Glutamine-rich maize seed protein and promoter
12/21/2006	US20060288442 Use of mixed duplex oligonucleotides to effect localized genetic changes in plants
12/21/2006	US20060288438 Novel miniature inverted-repeat transposable elements (MITEs)-like element and transcriptional activation element
12/21/2006	US20060288437 Zinc finger-based drug-dependent gene regulation system
12/21/2006	US20060288436 Screening systems and methods for identifying modulators of xenobioticmetabolism
12/21/2006	US20060288435 CD9/CD81 double-deficient non-human animal
12/21/2006	US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders
12/21/2006	US20060288433 Selecting a domestic animal for having desired genotypic properties bytesting the animal for the presence of a parentally imprinted quantitative trait locus; particularly selecting properties related to muscle mass, fat deposition, sow prolificacy, and/or sow longevity in pigs
12/21/2006	US20060288431 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells
12/21/2006	US20060287514 Mammalian cytokine-like polypeptide-10
12/21/2006	US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer
12/21/2006	US20060287511 Process for producing zinc oxide-protein complex
12/21/2006	US20060287510 Crystallization of IGF-1
12/21/2006	US20060287508 Methods for stabilizing proteins
12/21/2006	US20060287507 Mammalian cytokine-like polypeptide-10
12/21/2006	US20060287506 Method for separating and concentrating biological materials using continuous-flow ultracentrifugation
12/21/2006	US20060287505 Of given amino acid sequence; useful for promoting wound healing and stimulating platelet proliferation; can use in treating autoimmune diseases and cancer
12/21/2006	US20060287504 Universal procedure for refolding recombinant proteins
12/21/2006	US20060287503 Analyzing fusion protein expression; biological screening
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287501 Soluble truncated polypeptides of the nogo-a protein
12/21/2006	US20060287432 Peptide purification by means of metal ion affinity chromatography
12/21/2006	US20060287249 Of EtO2C CH2 (R)Cgl-Aze-Pab-OH or its salt; high chemical and solid state stability; thrombin inhibitors
12/21/2006	US20060287237 RhoB as a suppressor of cancer cell growth, cell transformation, and metastasis
12/21/2006	US20060287236 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
12/21/2006	US20060287235 Crystallization of IGF-1
12/21/2006	US20060287230 Compositions which can be used for regulating the activity of parkin
12/21/2006	US20060287228 Expression of active human factor IX in mammary tissue of transgenic animals
12/21/2006	US20060287226 Characterization of a membrane estrogen receptor
12/21/2006	US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006	US20060287222 Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
12/21/2006	US20060286657 Novel bioconjugation reactions for acylating polyethylene glycol reagents
12/21/2006	US20060286645 Polynucleotide constructs for increased lysine production
12/21/2006	US20060286642 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/21/2006	US20060286641 Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof
12/21/2006	US20060286640 Process for production of polypeptides
12/21/2006	US20060286639 Complementary DNAs encoding proteins with signal peptides
12/21/2006	US20060286638 Cell lines
12/21/2006	US20060286637 Using transgenic yeast as bioreactor for generation of sialylated glycoprotein
12/21/2006	US20060286636 VEGF variants
12/21/2006	US20060286635 Albumin fusion proteins
12/21/2006	US20060286634 Vector
12/21/2006	US20060286633 Methods for production of proteins
12/21/2006	US20060286632 Genetic engineered apolipoproteins has potent antioxidant activity on phospholipid surfaces; cardiovascular disorders, antiischemic agents, bone disorders, antiinflammatory agents
12/21/2006	US20060286631 Method for preparating t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene
12/21/2006	US20060286629 Methionine aminopeptidase enzymes; Wild-type Escherichia coli Met-AP; applying Qcyclase to the a peptide followed by purification on a cation exchange column
12/21/2006	US20060286607 Isolating nucleic acid encoding a plant polypeptide for use in generating disease resistant plants; obtain library, incubate with probe, recover clone, transform plant, propagate, evaluate for disease resistance
12/21/2006	US20060286605 Calcium biosensor polypeptides and methods of use
12/21/2006	US20060286603 Combinatorial libraries of monomer domains
12/21/2006	US20060286597 Aortic carboxypeptidase-like polypeptide
12/21/2006	US20060286593 Transforming Growth Factor Alpha HI
12/21/2006	US20060286584 Compositions and methods for the regulation of cell proliferation and apoptosis
12/21/2006	US20060286581 Heteroconfigurational Polynucleotides and Methods of Use
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	US20060286124 Vaccine compositions and methods of treating coronavirus infection
12/21/2006	US20060286122 Modulation of angiogenesis by Bartonella henselae
12/21/2006	US20060286119 Compositions and methods for treatment of chronic and infectious diseases
12/21/2006	US20060286118 Lawsonia intracllularis subunit vaccine
12/21/2006	US20060286117 Neuronally expressed stem cell factor modulates angiogenesis and neural stem cell migration to areas of brain injury
12/21/2006	US20060286115 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule
12/21/2006	US20060286114 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
12/21/2006	US20060286113 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits
12/21/2006	US20060286111 Tumor necrosis factor related ligand
12/21/2006	US20060286110 Bax-responsive genes for drug target identification in yeast and fungi
12/21/2006	US20060286104 Superagonistic anti-CD28 antibodies
12/21/2006	US20060286102 Cell surface receptor isoforms and methods of identifying and using the same
12/21/2006	US20060286099 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286098 Derived from cocaine linked to cholera B toxin; antibodies; for treatment of cocaine addiction; immunization
12/21/2006	US20060286097 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286096 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286095 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286094 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286093 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting ztnf4 activity
12/21/2006	US20060286091 RelA-ASSOCIATED INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
12/21/2006	US20060286085 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
12/21/2006	US20060286075 Method and compositions for treating hepatocellular cancer
12/21/2006	US20060286074 Methods for immunotherapy of cancer
12/21/2006	US20060286069 G-CSF Conjugates
12/21/2006	US20060286068 Polypeptides exhibiting granulocyte colony-stimulating factor (G-CSF) activity; conjugates between the polypeptides and a non-polypeptide moiety (PEG); for treatment of neutropenia or leukopenia; low in vitro bioactivity, long in vivo half-life, reduced receptor-mediated clearance
12/21/2006	US20060286066 Pegylated immunoglobulin variable region polypeptides
12/21/2006	US20060286065 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro
12/21/2006	US20060286035 Methods and compositions for modulating the interaction between adiponectin and its receptor
12/21/2006	US20060286031 Modulators of tissue regeneration
12/21/2006	DE102005027556A1 New Raf kinase inhibitor peptide useful in the preparation of medicament for the treatment of tumor
12/21/2006	DE10113042B4 HIV-Inhibitor Screening-System HIV inhibitor screening system
12/21/2006	DE10061110B4 Expression der Keratingene 8 und 18 zur Therapie von Tumoren, insbesondere des Mammakarzinoms Expression of keratin genes 8 and 18 for the treatment of tumors, especially of breast cancer
12/21/2006	CA2612794A1 Transglutaminase mediated conjugation of growth hormone
12/21/2006	CA2612304A1 Sulfate ion transporter gene and use thereof
12/21/2006	CA2612282A1 Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha
12/21/2006	CA2612281A1 Method for diagnosing alzheimer's disease
12/21/2006	CA2612180A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
12/21/2006	CA2612151A1 Agents and methods based on the use of the eda domain of fibronectin
12/21/2006	CA2612063A1 Oxyntomodulin analogues and their effects on feeding behaviour
12/21/2006	CA2611954A1 Dengue serotype 2 attenuated strain
12/21/2006	CA2611934A1 Dengue serotype 1 attenuated strain

1 ... 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 ... 2916